search button
Open Access

miRNA‑384‑5p regulates the progression of Parkinson's disease by targeting SIRT1 in mice and SH‑SY5Y cell

  • Authors:
    • Hongli Tao
    • Yan Liu
    • Yingjuan Hou

  • View Affiliations

  • Published online on: December 12, 2019     https://doi.org/10.3892/ijmm.2019.4426
  • Pages: 441-450

  • Copyright: © Tao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disorder. miR‑384‑5p expression has been shown to be increased in an in vitro model of PD; however, it remains unknown whether there are other molecules that can be regulated by miR‑384‑5p in in vivo and in vitro models of PD; thus, the present study aimed to elucidate this matter. Rotenone was applied for the establishment of in vitro and in vivo models of PD in the present study. Motor disability and equilibrium were determined by a swimming test and traction test, respectively. mRNA and protein levels were detected by reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) and western blot analysis, respectively. The association between miR‑384‑5p and Sirtuin 1 (SIRT1) expression was verified by dual luciferase reporter assay. The α‑synuclein aggregation was evaluated by immunofluorescence. The results from the in vitro model of PD demonstrated that, the mice in the PD group exhibited decreased scores in the swimming test and traction test, which were accompanied by increased α‑synuclein aggregation. In addition, the expression of miR‑384‑5p, which targeted the 3'untranslated region (3'UTR) of SIRT1, was verified to be increased in mice and SH‑SY5Y cells in the PD group, whereas SIRT1 exhibited the opposite changes. Moreover, increased mRNA and protein levels of p53 and FOXO1 were observed in mice and SH‑SY5Y cells in the PD group. In addition, the SH‑SY5Y cells in the PD group exhibited a higher cell apoptotic rate. On the whole, the findings of this study demonstrate that miRNA‑384‑5p promotes the progression of PD by targeting SIRT1.
View Figures
View References

Related Articles

Journal Cover

February-2020
Volume 45 Issue 2

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 5.7
  • Ranked Medicine Research and Experimental
    (total number of cites)
  • CiteScore: 12.3
  • CiteScore Rank: Q1: #28/347 Biochemistry, Genetics and Molecular Biology
  • Source Normalized Impact per Paper (SNIP): 1.022
  • SCImago Journal Rank (SJR): 1.167
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Tao H, Liu Y and Hou Y: miRNA‑384‑5p regulates the progression of Parkinson's disease by targeting SIRT1 in mice and SH‑SY5Y cell. Int J Mol Med 45: 441-450, 2020.
APA
Tao, H., Liu, Y., & Hou, Y. (2020). miRNA‑384‑5p regulates the progression of Parkinson's disease by targeting SIRT1 in mice and SH‑SY5Y cell. International Journal of Molecular Medicine, 45, 441-450. https://doi.org/10.3892/ijmm.2019.4426
MLA
Tao, H., Liu, Y., Hou, Y."miRNA‑384‑5p regulates the progression of Parkinson's disease by targeting SIRT1 in mice and SH‑SY5Y cell". International Journal of Molecular Medicine 45.2 (2020): 441-450.
Chicago
Tao, H., Liu, Y., Hou, Y."miRNA‑384‑5p regulates the progression of Parkinson's disease by targeting SIRT1 in mice and SH‑SY5Y cell". International Journal of Molecular Medicine 45, no. 2 (2020): 441-450. https://doi.org/10.3892/ijmm.2019.4426